ALERT!

Due to the COVID-19 virus outbreak, many of the Events you see on the calendar may be delayed or canceled.
Please check with the event staff or venue to ensure the event is still happening as scheduled.

« Home

21 CFR Part 11 (Electronic Records/Signatures) Compliance for Computer Systems Regulated by FDA

Tuesday, March 10, 2020, 8:00 PM - 9:30 PM


OVERVIEW
The webinar will focus on the importance of ensuring that electronic record/electronic signature (ER/ES) capability built into FDA-regulated computer systems meets compliance with FDA 21 CFR Part 11. This includes development of a company philosophy and approach, and incorporating it into the overall computer system validation program and plans for individual systems that have this capability.
FDA’s 21 CFR Part 11 was enacted in the late 1990s and implementation success across the pharmaceutical and other regulated industries has been mixed. There are very specific limitations that arise when using ER/ES capability, such as the elimination of print capability to prevent users from making decisions based on a paper record as opposed to the electronic record.
It also requires very specific identification of users that ensures the person signing the record is the same person whose credentials are being entered and verified by the system.
Rule for changing passwords must be rigorously adhered to and the passwords must be kept secure. It is also critical that the system specify the exact meaning of the signature. It may be that the person conducted the work, recorded the result, reviewed the result, or approved the result.
A person may simply be attesting to the fact that they reviewed the work and the signatures, and there was appropriate segregation of duties (i.e., the person recording the result is not the same as either the person reviewing or the person giving final approval).
A company must have specific policies and procedures in place that explicitly state responsibilities and provide guidance for implementing and using ER/ES capability. These must clarify the 21 CFR Part 11 regulations and provide insight as to the way the company interprets their responsibility for meeting it.
As FDA continues to evolve and change due to the many factors that influence the regulatory environment, companies must be able to adapt. New technologies will continue to emerge that will change the way companies do business.
While many of these are intended to streamline operations, reducing time and resources, some unintentionally result in added layers of oversight that encumber a computer system validation program and require more time and resources, making the technology unattractive from a cost-benefit perspective.
WHY SHOULD YOU ATTEND
You should attend this webinar if you are responsible for planning, executing or managing the implementation of any system governed by FDA regulations that uses ER/ES capability, or if you are maintaining or supporting such a system.
Effective and compliant computer system validation is critical to any pharmaceutical or FDA-regulated organization. During the past 30 years, best practices that have been developed that will ensure that validation activities are cost-effective while meeting all aspects of FDA compliance.
There is an enormous body of documentation and information available that can be overwhelming. This course will provide a condensed overview of the key practices that deliver the best results by directing the attendees to the most critical and cost-effective methods, techniques and tools available.
AREAS COVERED
• Computer System Validation (CSV)
• System Development Life Cycle (SDLC) methodologies
• Good “Variable” Practice (GxP) (Good Manufacturing Practice (GMP), Good Laboratory Practice (GLP), Good Clinical Practice (GCP))
• Validation strategy
• System risk assessment
• GAMP 5 “V” Model
• 21 CFR Part 11 requirements
• Electronic Records/Electronic Signatures (ER/ES)
• Data integrity
• Security, access, change control and audit trail
• Policies and procedures
• Training and organizational change management
• Industry best practices and common pitfalls
LEARNING OBJECTIVES
• Gain an understanding of FDA’s 21 CFR Part 11 Electronic Records/Electronic Signatures (ER/ES)

Cost: Live Session for one participant $199 Corporate Live Session Group – Max 10 Participants from one location. $549 Recorded Session Get unlimited access to the link for six months $219 Training DVD or USB Flash Drive MP3 files, PDF presentation and reference manual will be delivered on a CD $399 Super Combo Offer 1 Live and Recorded webinar $329 Super Combo Offer 2 Live and Training CD $499

Improve this event listing

Venue

26468 E Walker Dr, Aurora, Colorado 80016-6104
Aurora, CO 80016

View Map | Get Directions

More Event Ideas


Powered by Datasphere

Event data provided by Eventful

Free Coupons in Colorado Springs / Pueblo Add Your Coupon to LocalSaver

Close

What can we do for you?

Thank you for your input. Please fill out the form below and provide as much information as possible about updates to this event or venue.

Send